Skip to main content

Table 1 The baseline characteristics of patients with CSP-I and CSP-II group

From: Clinical efficacy and safety of high-intensity focused ultrasound (HIFU) ablation in treatment of cesarean scar pregnancy (CSP) I and II

Characteristics

CSP-I(n = 101)

CSP-II(n = 52)

p value

Age (year)

31.56 ± 4.05

33.61 ± 4.46

0.231

Gestational days (day)

55.75 ± 6.13

57.85 ± 5.19

0.457

Pretreatment HCG (mIU/ml)a

37,438.10 (154.5-65,277)

32,688.63 (71-54,962)

0.692

Gestational sac/mass diameter (mm)

35.17 ± 7.05

36.12 ± 8.60

0.544

Myometrium thickness (mm)

3.93 ± 1.25

2.55 ± 1.46

0.032

Fetal heart activity detected(n)b

0.121

 Yes

58

23

 NO

43

29

  1. Data are presented as mean ± SD, except for “Pretreatment HCG and fetal heart activity detected”
  2. aPretreatment b-HCG listed as medians
  3. bThe numbers for fetal heart activity detected are listed according to respective groups